PAVmed Inc. financial data

Symbol
PAVM, PAVMZ on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
360 Madison Avenue, 25 Th Floor, New York, New York
State of incorporation
Delaware
Fiscal year end
December 31
Former names
PAXmed Inc. (to 3/26/2015)
Latest financial report
Q1 2024 - May 13, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 60.5 % -54.8%
Debt-to-equity -115 % +99.5%
Return On Equity 401 %
Return On Assets -148 % -12.7%
Operating Margin -2.07K %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 9.32M shares -90.5%
Common Stock, Shares, Outstanding 8.86M shares -91.2%
Entity Public Float 38.6M USD -45.2%
Common Stock, Value, Issued 9K USD -91.1%
Weighted Average Number of Shares Outstanding, Basic 8.69M shares +34.3%
Weighted Average Number of Shares Outstanding, Diluted 8.69M shares +34.3%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 1M USD
Revenue from Contract with Customer, Excluding Assessed Tax 3.02M USD +126%
Cost of Revenue 6.82M USD +48.5%
Research and Development Expense 12.2M USD -48.1%
Selling and Marketing Expense 17.4M USD -12.9%
General and Administrative Expense 27.2M USD -35.7%
Costs and Expenses 65.4M USD -29.2%
Operating Income (Loss) -62.4M USD +32%
Nonoperating Income (Expense) -4.48M USD -147%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -75.6M USD +28.6%
Net Income (Loss) Attributable to Parent -61.5M USD +31.7%
Earnings Per Share, Basic -9 USD/shares +48.9%
Earnings Per Share, Diluted -9 USD/shares +5.76%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 25.5M USD -48.2%
Accounts Receivable, after Allowance for Credit Loss, Current 67K USD +148%
Inventory, Net 410K USD
Assets, Current 29.6M USD -45.1%
Property, Plant and Equipment, Net 1.6M USD -29.3%
Operating Lease, Right-of-Use Asset 3.89M USD -24.9%
Intangible Assets, Net (Excluding Goodwill) 1.05M USD -64.2%
Other Assets, Noncurrent 1.15M USD +6.3%
Assets 37.3M USD -42.9%
Accounts Payable, Current 1.49M USD +18%
Employee-related Liabilities, Current 2.51M USD +29.2%
Accrued Liabilities, Current 6.66M USD +78.8%
Liabilities, Current 55M USD +8.84%
Operating Lease, Liability, Noncurrent 2.81M USD -28.5%
Liabilities 57.8M USD +6.14%
Retained Earnings (Accumulated Deficit) -310M USD -25.8%
Stockholders' Equity Attributable to Parent -68.8M USD -212%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -20.6M USD -290%
Liabilities and Equity 37.3M USD -42.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -13.1M USD +19.9%
Net Cash Provided by (Used in) Financing Activities 19M USD -23.6%
Net Cash Provided by (Used in) Investing Activities -42K USD -104%
Common Stock, Shares Authorized 50M shares -80%
Common Stock, Shares, Issued 94.5M shares +9.43%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 5.9M USD -38.2%
Deferred Tax Assets, Valuation Allowance 93.6M USD +62.8%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 94.8M USD +62.5%
Operating Lease, Liability 4.15M USD -20.3%
Depreciation 911K USD +35.4%
Payments to Acquire Property, Plant, and Equipment 42K USD +61.5%
Lessee, Operating Lease, Liability, to be Paid 4.95M USD -21.8%
Property, Plant and Equipment, Gross 3.5M USD +7.46%
Operating Lease, Liability, Current 1.33M USD +5.46%
Lessee, Operating Lease, Liability, to be Paid, Year Two 794K USD +2.72%
Lessee, Operating Lease, Liability, to be Paid, Year One 841K USD -52.3%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 806K USD -29.1%
Lessee, Operating Lease, Liability, to be Paid, Year Three 624K USD -13.8%
Deferred Tax Assets, Operating Loss Carryforwards 67.8M USD +83%
Deferred Federal Income Tax Expense (Benefit) -16.8M USD +30.8%
Preferred Stock, Shares Authorized 20M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 472K USD -20.5%
Operating Lease, Payments 476K USD +37.6%
Additional Paid in Capital 238M USD +7.51%
Amortization of Intangible Assets 1.89M USD -12.8%
Depreciation, Depletion and Amortization 586K USD -19.4%
Deferred State and Local Income Tax Expense (Benefit) -19.3M USD -274%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%